We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BATS:LSEBritish American Tobacco p.l.c. Analysis

Data as of 2026-09-15 - not real-time

£4,250.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

British American Tobacco p.l.c. trades at £4,250.00, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 10.2%. Relative strength is 42.4 — neutral — and the MACD signal is bullish. The recent range runs from support at £4,002.00 up to resistance at £4,273.00.
Valuation screens as undervalued, on a P/E of 14.6 with no clean sector comparison available. Consensus targets land 21.1% above where the shares trade now. The 5.98% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 24.1%, a beta of 0.12 and a maximum drawdown of 18.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

British American Tobacco LSE:BATS reported first-half 2026 results that were broadly in line with expectations, with...Yahoo Finance1monEarnings To Watch: British American Tobacco PLC LSE:BATS Q2 2026 -- GF Value Sees 38% DownsideThe...Yahoo Finance1monWhat Does British American Tobacco LSE:BATS New Tech Partnership Mean For Investors?

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 4394.81
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 4394.81
  • Analyst targets imply +21.1% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +21.1% versus the current price
  • Profit margin of 25.0% is healthy
  • P/E ratio of 14.6

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin24.99%
P/E Ratio14.6
ROE13.42%
ROA5.12%
Debt/Equity72.15
P/B Ratio2.0
Op. Cash Flow£7.4B
Free Cash Flow£3.5B

Technical Analysis

TrendBearish
RSI42.4
Support£4,002.00
Resistance£4,273.00
MA 20£4,135.75
MA 50£4,348.32
MA 200£4,394.82
MACDBullish
VolumeIncreasing
Fear & Greed Index90.89

Valuation

Fair Value£635.46
Target Price£5,146.15
Upside/Downside21.09%
GradeUndervalued
TypeValue
Dividend Yield5.98%

Risk Assessment

Beta0.12
Volatility24.09%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.